
Quantitative Imaging Systems LLC (AKA: Qi) Profile last edited on: 6/17/2022
CAGE: 6S5J8
UEI: K5ELZZPK73V9
Business Identifier: New types of cancer treatment Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 12
County: Allegheny
Congr. District: 12
County: Allegheny
Public Profile
Quantitative Imaging Systems (Qi) is a biotechnology business developing imaging systems with a primary focus use of digital imaging microscopy in the cancer space. Combining next generation image analytics and visualization technologies with recent advances in reagents and optics, Qi is amepting to break barriers in resolution, color, and dimensionality. Tissue architectural information can now be augmented with highly multiplexed single cell analysis, providing a wealth of information that was not previously available. QiTissue combines the power of cell based analytics, machine learning, and visualization enabling unprecedented insights into spatial concepts: tumor nests, islands of resistance, interactions with stroma during metastatic progression, and the effect of each type of immune cell.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2023 | 2 | NIH | $1,913,568 | |
Project Title: Ultra-high content analyses of circulating and solid tumor cells: A diagnostic reference system for disease burden | ||||
2021 | 1 | NIH | $399,955 | |
Project Title: Tools And Technologies For Visualizing Multi-Scale Data | ||||
2019 | 2 | NIH | $1,724,521 | |
Project Title: Ultra-High Content Analysis (UHCA) of Single Cells in Tissue: 60+ channel immunofluorescence labeling kits and companion imaging software for everyone |
Key People / Management
Michel Nederlof -- Founder, President and CEO
Damir Sudar -- Chief Science Officer
Damir Sudar -- Chief Science Officer